Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm(2) on the chest: A phase 3 randomized controlled trial

摘要

Background: Ingenol mebutate (IngMeb) 0.015% or 0.05% is approved for actinic keratosis (AK) areas of 25 cm(2) or less; some patients require treatment of larger fields.